Stockreport

KaliVir doses first subject in Phase I/Ib solid tumour treatment trial [Yahoo! Finance]

ASTELLAS PHARMA UNSP/ADR  (ALPMY) 
NASDAQ:AMEX Investor Relations: astellas.com/jp/en/investors
PDF Patients will receive the treatment either by direct tumour injection or intravenous infusion. The dose escalation portion aims to establish the highest tolerated dos [Read more]